Related Experiment Videos
[Common infections in immunocompromised patients]
Schweizerische Medizinische Wochenschrift
|May 2, 1987
Summary
Understanding host defense abnormalities is key to predicting infections in immunocompromised patients. Tailoring antimicrobial therapy based on specific immune defects improves patient outcomes and manages infectious complications.
Area of Science:
- Immunology
- Infectious Diseases
- Clinical Medicine
Background:
- Immunocompromised patients face heightened risks of severe infections.
- Clinical detection of infections varies based on the type of immune compromise.
- Specific host defense defects predict likely pathogens and infection courses.
Purpose of the Study:
- To elucidate the relationship between host defense abnormalities and infectious syndromes.
- To guide antimicrobial therapy decisions based on immune status.
- To illustrate these principles with common infectious diseases.
Main Methods:
- Review of host defense mechanisms (cell-mediated, humoral, polymorphonuclear leukocyte, anatomical barriers).
- Correlation of specific defects with characteristic pathogens.
- Case examples of urinary tract infections, Candida mucositis, Varicella-Zoster virus infections, and fever in asplenic patients.
Main Results:
- Defects in cell-mediated immunity increase susceptibility to intracellular pathogens.
- Impaired humoral immunity raises risk from encapsulated, extracellular organisms.
- Neutrophil defects predispose to Staphylococcus aureus infections.
- Compromised anatomical barriers lead to infections from colonizing flora.
Conclusions:
- Precise knowledge of host defense status is crucial for predicting and managing infections.
- Antimicrobial therapy must be individualized based on a thorough evaluation of immune function.
- Understanding these relationships aids in managing diverse infectious complications in immunocompromised individuals.